Clincosm LogoSign in Get a demo

Whole Body Periodic Acceleration on Activity and Sleep In Parkinson's Disease

Sponsor
New York Institute of Technology (Other)
Overall Status
Completed
CT.gov ID
NCT02874261
Collaborator
(none)
10
Enrollment
1
Location
1
Arm
25
Duration (Months)
0.4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Whole-body periodic acceleration (WBPA) is a new, non-invasive, and promising therapy for a diverse and growing list of disorders including cardiovascular disease. During WBPA, patients lie in the supine position on a bed that is capable of translating back and forth parallel to the ground, along the head-to-foot axis of the patient. Thus, this treatment is best described as a form of "passive exercise." The frequency of the translation (up to 180 cycles/minute; cpm) as well as the distance traveled (2-24mm) by the bed can be adjusted by the patient or health care professional.

The science behind the therapeutic effects of WBPA still remains largely unknown.

The investigators are observing how WBPA may impact on sleep and activity in individuals with Parkinson's disease.

Condition or Disease Intervention/Treatment Phase
  • Device: Whole Body Periodic Acceleration
 N/A

Detailed Description

Sleep disturbances are common in individuals with Parkinson's Disease. Whole-body periodic acceleration (WBPA) is a new, non-invasive, and promising therapy for a diverse and growing list of disorders. During WBPA, patients lie in the supine position on a bed that is capable of translating back and forth parallel to the ground, along the head-to-foot axis of the patient. Thus, this treatment is best described as a form of "passive exercise." WBPA has been shown in previous studies to increase nitric oxide. Increased levels of nitric oxide have been shown to improve sleep patterns in other populations. The current pilot study will investigate how WBPA will impact upon sleep disturbances in subjects with Parkinson's disease who suffer from abnormal sleep patterns. The investigators will record sleep patterns and activity levels using a Jawbone U3® activity monitor.

Study Design

Study Type:
Interventional
Actual Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effects of Whole Body Periodic Acceleration on Activity and Sleep In Parkinson's Disease
Study Start Date :
May 1, 2015
Actual Primary Completion Date :
May 1, 2017
Actual Study Completion Date :
Jun 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Whole Body Periodic Acceleration

Whole-body periodic acceleration (WBPA) is a new, non-invasive, and promising therapy for a diverse and growing list of disorders including cardiovascular disease 6. During WBPA, patients lie in the supine position on a bed that is capable of translating back and forth parallel to the ground, along the head-to-foot axis of the patient. Thus, this treatment is best described as a form of "passive exercise." The frequency of the translation is 120 cycles/minute; cpm) as well as a distance traveled 16 mm.

Device: Whole Body Periodic Acceleration
oscillating bed that the subject will lie on 3 days a week for 45 minutes at 140 cycles per minute.
Other Names:
  • WBPA

    		•

    Outcome Measures

    Primary Outcome Measures

    1. Sleep patterns using an activity monitor on the wrist [6 weeks]

      The investigators will record sleep patterns a week before WBPA through out the 4 weeks of WBPA and then one week post WBPA using an activity monitor on the wrist

    Secondary Outcome Measures

    1. Pittsburgh Sleep Quality Index [6 weeks]

      This is a quantitative tool to measure sleep as well as an activity monitor twenty -four hours for seven days at a time

    2. Physical Activity (steps per day using an activity monitor on the wrist) [6 weeks]

      The investigators will record steps per day a week before WBPA through out the 4 weeks of WBPA and then one week post WBPA using an activity monitor on the wrist

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    50 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    • Healthy individuals between the ages of 50-80

    • Individuals with Parkinsons disease between the ages of 50-80

    • Individuals with a smart phone

    Exclusion Criteria:
    • Any condition that prevents you from lying flat on your back, any other neurological condition than Parkinson's disease.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 NYIT Old Westbury New York United States 11568568

    Sponsors and Collaborators

    • New York Institute of Technology

    Investigators

    • Principal Investigator: Veronica Southard, DPT, NYIT

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    New York Institute of Technology
    ClinicalTrials.gov Identifier:
    NCT02874261
    Other Study ID Numbers:
    • BHS-1124
    First Posted:
    Aug 22, 2016
    Last Update Posted:
    Oct 2, 2017
    Last Verified:
    Sep 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Additional relevant MeSH terms:
    Parkinson Disease
    Sleep Wake Disorders

    Study Results

    No Results Posted as of Oct 2, 2017